Volume 14 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Branch of Organ Transplantation of Chinese Medical Association. Chinese experts consensus on the management of surgical site infection in solid organ transplantation (2022 edition)[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 11-23. doi: 10.3969/j.issn.1674-7445.2023.01.002
Citation: Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Branch of Organ Transplantation of Chinese Medical Association. Chinese experts consensus on the management of surgical site infection in solid organ transplantation (2022 edition)[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 11-23. doi: 10.3969/j.issn.1674-7445.2023.01.002

Chinese experts consensus on the management of surgical site infection in solid organ transplantation (2022 edition)

doi: 10.3969/j.issn.1674-7445.2023.01.002
  • Received Date: 2022-11-22
    Available Online: 2023-01-17
  • Publish Date: 2023-01-15
  • The quality of solid organ transplantation has been improved significantly in China in recent years. However, surgical site infection (SSI) is still a main factor affecting the survival of solid organ transplantation recipients. With the joint efforts of experts in fields of organ transplantation, infectious diseases, critical care medicine, laboratory medicine and clinical pharmacy, this expert consensus systematically summarizes the experiences of SSI management in solid organ transplantation in China, focusing on basic management principles, epidemiology, risk factors, special pathogen infection and diagnostic techniques of SSI. It aims to standardize the prevention measures of SSI in transplantation centers to reduce the incidence and mortality of SSI in solid organ transplantation recipients.

     

  • loading
  • [1]
    BERRÍOS-TORRES SI, UMSCHEID CA, BRATZLER DW, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection[J]. JAMA Surg, 2017, 152(8): 784-791. DOI: 10.1001/jamasurg.2017.0904.
    [2]
    ABBO LM, GROSSI PA, AST ID Community of Practice. Surgical site infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13589. DOI: 10.1111/ctr.13589.
    [3]
    ZHANG W, WANG W, KANG M, et al. Bacterial and fungal infections after liver transplantation: microbial epidemiology, risk factors for infection and death with infection[J]. Ann Transplant, 2020, 25: e921591. DOI: 10.12659/AOT.921591.
    [4]
    WU D, CHEN C, LIU T, et al. Epidemiology, susceptibility, and risk factors associated with mortality in carbapenem-resistant Gram-negative bacterial infections among abdominal solid organ transplant recipients: a retrospective cohort study[J]. Infect Dis Ther, 2021, 10(1): 559-573. DOI: 10.1007/s40121-021-00411-z.
    [5]
    中华医学会外科学分会外科感染与重症医学学组, 中国医师协会外科医师分会肠瘘外科医师专业委员会. 中国手术部位感染预防指南[J]. 中华胃肠外科杂志, 2019, 22(4): 301-314. DOI: 10.3760/cma.j.issn.1671-0274.2019.04.001.

    Surgical Infection and Critical Care Medicine Group of Surgical Branch of Chinese Medical Association, Fistula Surgeons Committee of Branch of Surgeons of Chinese Medical Doctor Association. Chinese guideline for the prevention of surgical site infection[J]. Chin J Gastrointest Surg, 2019, 22(4): 301-314. DOI: 10.3760/cma.j.issn.1671-0274.2019.04.001.
    [6]
    中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所. 中国实体器官移植供者来源感染防控专家共识(2018版)[J]. 中华器官移植杂志, 2018, 39(1): 41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Hospital Infection Control of Chinese Preventive Medicine Association, Institute of Antibiotics of Huashan Hospital of Fudan University. Expert consensus on infection prevention and control of donor-derived solid organ transplantation in China(2018 edition)[J]. Chin J Organ Transplant, 2018, 39(1): 41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
    [7]
    中华医学会器官移植学分会. 器官移植供者来源性感染诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4): 369-375. DOI: 10.3969/j.issn.1674-7445.2019.04.005.

    Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of donor-derived infection in organ transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(4): 369-375. DOI: 10.3969/j.issn.1674-7445.2019.04.005.
    [8]
    FIELDS AC, PRADARELLI JC, ITANI KMF. Preventing surgical site infections: looking beyond the current guidelines[J]. JAMA, 2020, 323(11): 1087-1088. DOI: 10.1001/jama.2019.20830.
    [9]
    薛晨, 陈志强, 张艳君, 等. 实体器官移植供者来源感染防控研究进展[J]. 中华医院感染学杂志, 2020, 30(4): 637-640. DOI: 10.11816/cn.ni.2020-191096.

    XUE C, CHEN ZQ, ZHANG YJ, et al. Advances in prevention and control of donor-derived infections in solid organ transplant recipients[J]. Chin J Nosocomiol, 2020, 30(4): 637-640. DOI: 10.11816/cn.ni.2020-191096.
    [10]
    部实, 任海霞, 陈凡. 实体器官移植术后常见机会感染的用药管理[J/CD]. 实用器官移植电子杂志, 2020, 8(1): 71-75. DOI: 10.3969/j.issn.2095-5332.2020.01.019.

    BU S, REN HX, CHEN F. Medication management of common opportunistic infections after solid organ transplantation[J/CD]. Prac J Organ Transplant (Electr Vers), 2020, 8(1): 71-75. DOI: 10.3969/j.issn.2095-5332.2020.01.019.
    [11]
    LING ML, APISARNTHANARAK A, ABBAS A, et al. APSIC guidelines for the prevention of surgical site infections[J]. Antimicrob Resist Infect Control, 2019, 8: 174. DOI: 10.1186/s13756-019-0638-8.
    [12]
    SUI M, ZHENG N, XU D, et al. Colistin sulfate for decontamination of preservation fluid in kidney transplantation to decrease the incidence of donor-derived infections caused by multidrug-resistant Gram-negative bacteria[J]. Transpl Infect Dis, 2022, 24(3): e13820. DOI: 10.1111/tid.13820.
    [13]
    GONG L, ZHANG L, LIU X, et al. Distribution and antibiotic susceptibility pattern of multidrug-resistant bacteria and risk factors among kidney transplantation recipients with infections over 13 years: a retrospective study[J]. Infect Drug Resist, 2021, 14: 5661-5669. DOI: 10.2147/IDR.S318941.
    [14]
    中国碳青霉烯耐药肠杆菌科细菌感染诊治与防控专家共识编写组, 中国医药教育协会感染疾病专业委员会, 中华医学会细菌感染与耐药防控专业委员会. 中国碳青霉烯耐药肠杆菌科细菌感染诊治与防控专家共识[J]. 中华医学杂志, 2021, 101(36): 2850-2860. DOI: 10.3760/cma.j.cn112137-20210219-00438.

    Expert Consensus Compilation Group for Diagnosis, Treatment and Prevention of Carbapenem-resistant Enterobacteriaceae Bacterial Infection in China, Infectious Diseases Committee of Chinese Medical Education Association, Bacterial Infection and Drug Resistance Control Committee of Chinese Medical Association. Expert consensus on diagnosis, treatment and prevention of carbapenem-resistant Enterobacteriaceae bacterial infections in China[J]. Natl Med J China, 2021, 101(36): 2850-2860. DOI: 10.3760/cma.j.cn112137-20210219-00438.
    [15]
    MILLER WR, MURRAY BE, RICE LB, et al. Vancomycin-resistant enterococci: therapeutic challenges in the 21st century[J]. Infect Dis Clin North Am, 2016, 30(2): 415-439. DOI: 10.1016/j.idc.2016.02.006.
    [16]
    徐骁, 张文会, 刘治坤. 重视肝移植受者长期管理[J]. 中华器官移植杂志, 2021, 42(3): 129-130. DOI: 10.3760/cma.j.cn421203-20210303-00080.

    XU X, ZHANG WH, LIU ZK. Pay attention to long-term survival of liver transplant recipients[J]. Chin J Organ Transplant, 2021, 42(3): 129-130. DOI: 10.3760/cma.j.cn421203-20210303-00080.
    [17]
    SELIMOĞLU MA, KAYA S, GÜNGÖR Ş, et al. Infection risk after paediatric liver transplantation[J]. Turk J Pediatr, 2020, 62(1): 46-52. DOI: 10.24953/turkjped.2020.01.007.
    [18]
    KIM W, KIM S, OH J, et al. Incidence and risk factors for herpes zoster after adult liver transplantation[J]. Ann Surg Treat Res, 2019, 96(2): 95-99. DOI: 10.4174/astr.2019.96.2.95.
    [19]
    申存毅, 薛峰, 李亚鹏, 等. 肝移植后发生腹腔感染的危险因素分析[J]. 中华消化外科杂志, 2021, 20(11): 1184-1190. DOI: 10.3760/cma.j.cn115610-20211008-00491.

    SHEN CY, XUE F, LI YP, et al. Risk factors analysis of abdominal infection after liver transplantation[J]. Chin J Dig Surg, 2021, 20(11): 1184-1190. DOI: 10.3760/cma.j.cn115610-20211008-00491.
    [20]
    中国医师协会器官移植医师分会, 中华医学会器官移植学分会肝移植学组. 中国肝移植受者代谢病管理专家共识(2019版)[J/CD]. 中华移植杂志(电子版), 2019, 13(3): 187-194. DOI: 10.3877/cma.j.issn.1674-3903.2019.03.006.

    Branch of Organ Transplant Physician of Chinese Medical Doctor Association, Liver Transplantation Group of Branch of Organ Transplantation of Chinese Medical Association. Expert consensus on the management of metabolic diseases in Chinese liver transplant recipients (2019 edition)[J/CD]. Chin J Transplant (Electr Edit), 2019, 13(3): 187-194. DOI: 10.3877/cma.j.issn.1674-3903.2019.03.006.
    [21]
    张飞, 廖贵益. 供者来源性感染对肾移植受者预后的影响[J]. 器官移植, 2021, 12(6): 700-706. DOI: 10.3969/j.issn.1674-7445.2021.06.009.

    ZHANG F, LIAO GY. Effect of donor-derived infection on clinical prognosis of kidney transplant recipients[J]. Organ Transplant, 2021, 12(6): 700-706. DOI: 10.3969/j.issn.1674-7445.2021.06.009.
    [22]
    刘彦妤, 岳慧杰, 陈晨, 等. 肾移植受者围手术期感染危险因素及预防用抗菌药物合理性的分析[J]. 医学研究生学报, 2020, 33(11): 1181-1186. DOI: 10.16571/j.cnki.1008-8199.2020.11.012.

    LIU YY, YUE HJ, CHEN C, et al. Analysis of perioperative infection risk factors and rationality of prophylactic antibiotics in renal transplant recipients[J]. J Med Postgra, 2020, 33(11): 1181-1186. DOI: 10.16571/j.cnki.1008-8199.2020.11.012.
    [23]
    刘炎忠, 柏宏伟, 钱叶勇, 等. DCD时代肾移植术后耐碳青霉烯类肺炎克雷伯菌感染的治疗经验总结[J]. 器官移植, 2020, 11(1): 76-81. DOI: 10.3969/j.issn.1674-7445.2020.01.012.

    LIU YZ, BAI HW, QIAN YY, et al. Summary of treatment experience of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation in DCD era[J]. Organ Transplant, 2020, 11(1): 76-81. DOI: 10.3969/j.issn.1674-7445.2020.01.012.
    [24]
    SHIELDS RK, CLANCY CJ, MINCES LR, et al. Epidemiology and outcomes of deep surgical site infections following lung transplantation[J]. Am J Transplant, 2013, 13(8): 2137-2145. DOI: 10.1111/ajt.12292.
    [25]
    张秀红, 缪丽燕, 陈静瑜, 等. 呼吸重症监护病房肺移植术后患者早期感染病原菌分布与耐药性[J]. 中国感染控制杂志, 2020, 19(9): 785-790. DOI: 10.12138/j.issn.1671-9638.20205048.

    ZHANG XH, MIAO LY, CHEN JY, et al. Distribution and antimicrobial resistance of pathogens causing early infection in patients after lung transplantation in a respiratory intensive care unit[J]. Chin J Infect Control, 2020, 19(9): 785-790. DOI: 10.12138/j.issn.1671-9638.20205048.
    [26]
    胡春晓, 李小杉, 卫栋, 等. 前进中的肺移植事业——我国肺移植发展现状及未来[J]. 器官移植, 2020, 11(2): 204-207. DOI: 10.3969/j.issn.1674-7445.2020.02.005.

    HU CX, LI XS, WEI D, et al. The development of lung transplantation: current situation and future of lung transplantation in China[J]. Organ Transplant, 2020, 11(2): 204-207. DOI: 10.3969/j.issn.1674-7445.2020.02.005.
    [27]
    ALSAEED M, HUSAIN S. Infections in heart and lung transplant recipients[J]. Crit Care Clin, 2019, 35(1): 75-93. DOI: 10.1016/j.ccc.2018.08.010.
    [28]
    胡晓红, 邓敏, 史嘉玮. 心血管外科ICU 66例心脏移植患者医院感染发病率[J]. 中国感染控制杂志, 2016, 15(8): 552-555. DOI: 10.3969/j.issn.1671-9638.2016.08.004.

    HU XH, DENG M, SHI JW. Incidence of healthcare-associated infection in 66 patients undergoing heart transplantation in a cardiovascular surgical intensive care unit[J]. Chin J Infect Control, 2016, 15(8): 552-555. DOI: 10.3969/j.issn.1671-9638.2016.08.004.
    [29]
    《应用抗菌药物防治外科感染指导意见》撰写协作组. 应用抗菌药物防治外科感染的指导意见(草案) ⅩⅧ——临床心脏移植感染的预防与治疗[J]. 中华外科杂志, 2006, 44(22): 1563-1564. DOI: 10.3760/j:issn:0529-5815.2006.22.016.

    Writing Collaborative Group of "Guidelines on the use of antibiotics for the prevention and treatment of surgical infections". Guidance on the Application of Antibiotics to the Prevention and Treatment of Surgical Infections (Draft) ⅩⅧ——prevention and treatment of infection in clinical heart transplantation[J]. Chin J Surg, 2006, 44(22): 1563-1564. DOI: 10.3760/j:issn:0529-5815.2006.22.016.
    [30]
    赵龙, 王金海. 小肠移植进展[J]. 中华炎性肠病杂志, 2022, 6(1): 36-41. DOI: 10.3760/cma.j.cn101480-20211117-00094.

    ZHAO L, WANG JH. Progress in intestinal transplantation[J]. Chin J Inflamm Bowel Dis, 2022, 6(1): 36-41. DOI: 10.3760/cma.j.cn101480-20211117-00094.
    [31]
    SPENCE AB, NOVICK E, NATARAJAN M, et al. Bloodstream infections among intestinal and multivisceral transplant recipients[J]. Transpl Infect Dis, 2021, 23(4): e13668. DOI: 10.1111/tid.13668.
    [32]
    李元新, 李宁, 李幼生, 等. 小肠移植后并发侵袭性真菌感染的治疗[J]. 中华器官移植杂志, 2010, 31(2): 97-100. DOI: 10.3760/cma.j.issn.0254-1785.2010.02.010.

    LI YX, LI N, LI YS, et al. Invasive fungal infection after small bowel transplantation[J]. Chin J Organ Transplant, 2010, 31(2): 97-100. DOI: 10.3760/cma.j.issn.0254-1785.2010.02.010.
    [33]
    VIEHMAN JA, CLANCY CJ, CLARKE L, et al. Surgical site infections after liver transplantation: emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies[J]. Transplantation, 2016, 100(10): 2107-2114. DOI: 10.1097/TP.0000000000001356.
    [34]
    中华医学会器官移植学分会. 器官移植术后耐药菌感染诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445.2019.04.002

    Branch of Organ Transplantation of Chinese Medical Association. Technical specification for diagnosis and treatment of drug-resistant bacterial infection after organ transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(4): 352-358. DOI: 10.3969/j.issn.1674-7445.2019.04.002.
    [35]
    CERVERA C, VAN DELDEN C, GAVALDÀ J, et al. Multidrug-resistant bacteria in solid organ transplant recipients[J]. Clin Microbiol Infect, 2014, 20(Suppl 7): 49-73. DOI: 10.1111/1469-0691.12687.
    [36]
    SILVA JT, FERNÁNDEZ-RUIZ M, AGUADO JM. Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment[J]. Curr Opin Infect Dis, 2018, 31(6): 499-505. DOI: 10.1097/QCO.0000000000000488.
    [37]
    TIMSIT JF, SONNEVILLE R, KALIL AC, et al. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients[J]. Intensive Care Med, 2019, 45(5): 573-591. DOI: 10.1007/s00134-019-05597-y.
    [38]
    SAHIN SZ, AKALIN H, ERSOY A, et al. Invasive fungal infections in renal transplant recipients: epidemiology and risk factors[J]. Mycopathologia, 2015, 180(1/2): 43-50. DOI: 10.1007/s11046-015-9875-4.
    [39]
    中华医学会器官移植学分会. 器官移植受者侵袭性真菌病临床诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002.

    Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for clinical diagnosis and treatment for invasive fungal disease in organ transplant recipients (2019 edition)[J]. Organ Transplant, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002.
    [40]
    中华医学会器官移植学分会. 器官移植受者非结核分枝杆菌病临床诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4): 364-368. DOI: 10.3969/j.issn.1674-7445.2019.04.004.

    Branch of Organ Transplantation of Chinese Medical Association. Technical specification for clinical diagnosis and treatment of nontuberculosis mycobacteria in organ transplant recipients (2019 edition)[J]. Organ Transplant, 2019, 10(4): 364-368. DOI: 10.3969/j.issn.1674-7445.2019.04.004.
    [41]
    SUBRAMANIAN AK, THEODOROPOULOS NM, Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation[J]. Clin Transplant, 2019, 33(9): e13513. DOI: 10.1111/ctr.13513.
    [42]
    吕晶南, 余方友. 分子生物学技术在感染性疾病诊断中的应用进展[J]. 临床检验杂志, 2021, 39(2): 81-85. DOI: 10.13602/j.cnki.jcls.2021.02.01.

    LYU JN, YU FY. Advances in the application of molecular biology techniques in the diagnosis of infectious diseases[J]. Clin J Clin Lab Sci, 2021, 39(2): 81-85. DOI: 10.13602/j.cnki.jcls.2021.02.01.
    [43]
    刘婉彤, 童梅, 林福玉, 等. 分子诊断技术的临床应用进展[J]. 生物技术通讯, 2020, 31(2): 240-250. DOI: 10.3969/j.issn.1009-0002.2020.02.019.

    LIU WT, TONG M, LIN FY, et al. Advances of clinical applications of molecular diagnostic techniques[J]. Lett Biotechnol, 2020, 31(2): 240-250. DOI: 10.3969/j.issn.1009-0002.2020.02.019.
    [44]
    DUAN H, LI X, MEI A, et al. The diagnostic value of metagenomic next-generation sequencing in infectious diseases[J]. BMC Infect Dis, 2021, 21(1): 62. DOI: 10.1186/s12879-020-05746-5.
    [45]
    ANGELETTI S, CICCOZZI M. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: an updating review[J]. Infect Genet Evol, 2019, 76: 104063. DOI: 10.1016/j.meegid.2019.104063.
    [46]
    韩丹. POCT的临床发展现状及精细化管理探讨[J]. 中国卫生产业, 2019, 16(33): 104-106. DOI: 10.16659/j.cnki.1672-5654.2019.33.104.

    HAN D. Discussion on clinical development status and refined management of POCT[J]. China Health Industry, 2019, 16(33): 104-106. DOI: 10.16659/j.cnki.1672-5654.2019.33.104.
    [47]
    BRAUN SD, MONECKE S, THÜRMER A, et al. Rapid identification of carbapenemase genes in Gram-negative bacteria with an oligonucleotide microarray-based assay[J]. PloS One, 2014, 9(7): e102232.
    [48]
    杨墨丹, 鲁迪, 陈俊丽, 等. 大数据时代背景下的中国肝移植质量提升[J/CD]. 实用器官移植电子杂志, 2020, 8(2): 93-95. DOI: 10.3969/j.issn.2095-5332.2020.02.004.

    YANG MD, LU D, CHEN JL, et al. The improvement of liver transplantation quality in China in the era of big data[J/CD]. Prac J Organ Transplant (Electr Vers), 2020, 8(2): 93-95. DOI: 10.3969/j.issn.2095-5332.2020.02.004.
    [49]
    魏绪勇, 徐骁, 郑树森. 面向临床, 推动我国肝移植创新发展[J]. 中华器官移植杂志, 2019, 40(3): 131-132. DOI: 10.3760/cma.j.issn.0254-1785.2019.03.002.

    WEI XX, XU X, ZHENG SS. Promoting the innovative development of liver transplantation in clinic in China[J]. Chin J Organ Transplant, 2019, 40(3): 131-132. DOI: 10.3760/cma.j.issn.0254-1785.2019.03.002.
    [50]
    PAREKH J, KO C, LAPPIN J, et al. A transplant-specific quality initiative-introducing TransQIP: a joint effort of the ASTS and ACS[J]. Am J Transplant, 2017, 17(7): 1719-1722. DOI: 10.1111/ajt.14315.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Article Metrics

    Article views (951) PDF downloads(261) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return